{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:55:29Z","timestamp":1790470529870,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"internal funding"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Achromobacter are emerging pathogens in cystic fibrosis patients. Mechanisms of resistance to fluoroquinolones are unknown in clinical isolates. Among non-fermenting Gram-negative bacilli, fluoroquinolone resistance is mostly due to amino acid substitutions in localized regions of the targets (GyrA, GyrB, ParC and ParE) named QRDRs, but also to efflux.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To explore quinolone resistance mechanisms in Achromobacter.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The putative QRDRs of GyrA, GyrB, ParC and ParE were sequenced in 62 clinical isolates, and in vitro one-step mutants obtained after exposure to fluoroquinolones. An in vitro mutant and its parental isolate were investigated by RNASeq and WGS. RT\u2013qPCR and gene inactivation were used to explore the role of efflux systems overexpression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We detected seven substitutions in QRDRs (Q83L\/S84P\/D87N\/D87G for GyrA, Q480P for GyrB, T395A\/K525Q for ParE), all in nine of the 27 clinical isolates with ciprofloxacin MIC \u226516\u2009mg\/L, whereas none among the in vitro mutants. The RND efflux system AxyEF-OprN was overproduced (about 150-fold) in the in vitro mutant NCF-39-Bl6 versus its parental strain NCF-39 (ciprofloxacin MICs 64 and 1.5\u2009mg\/L, respectively). A substitution in AxyT (putative regulator of AxyEF-OprN) was detected in NCF-39-Bl6. Ciprofloxacin MIC in NCF-39-Bl6 dropped from 64 to 1.5\u2009mg\/L following gene inactivation of either axyT or axyF. Substitutions in AxyT associated with overexpression of AxyEF-OprN were also detected in seven clinical strains with ciprofloxacin MIC \u226516\u2009mg\/L.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Target alteration is not the primary mechanism involved in fluoroquinolone resistance in Achromobacter. The role of AxyEF-OprN overproduction was demonstrated in one in vitro mutant.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa440","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T03:30:10Z","timestamp":1601523010000},"page":"297-304","source":"Crossref","is-referenced-by-count":13,"title":["Fluoroquinolone resistance in <i>Achromobacter<\/i> spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN"],"prefix":"10.1093","volume":"76","author":[{"given":"Arnaud","family":"Magallon","sequence":"first","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"},{"name":"UMR\/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Roussel","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-0669","authenticated-orcid":false,"given":"Catherine","family":"Neuwirth","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"},{"name":"UMR\/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tetu","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"},{"name":"UMR\/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Charlotte","family":"Cheiakh","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Boulet","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Varin","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Urbain","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bador","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"},{"name":"UMR\/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Amoureux","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, University Hospital of Dijon, BP 37013, 21070 Dijon CEDEX, France"},{"name":"UMR\/CNRS 6249 Chrono-environnement, University of Bourgogne-Franche-Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"2021012006032234000_dkaa440-B1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1099\/ijsem.0.003786","article-title":"Achromobacter veterisilvae sp. nov., from a mixed hydrogen-oxidizing bacteria enrichment reactor for microbial protein production","volume":"70","author":"Dumolin","year":"2020","journal-title":"Int J Syst Evol Microbiol"},{"key":"2021012006032234000_dkaa440-B2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2012.10.002","article-title":"Identification and distribution of Achromobacter species in cystic fibrosis","volume":"12","author":"Spilker","year":"2013","journal-title":"J Cyst Fibros"},{"key":"2021012006032234000_dkaa440-B3","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1017\/S0950268816001564","article-title":"Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples","volume":"144","author":"Amoureux","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2021012006032234000_dkaa440-B4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/AAC.01243-12","article-title":"Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump","volume":"57","author":"Bador","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nmni.2015.11.013","article-title":"Distribution of innate efflux-mediated aminoglycoside resistance among different Achromobacter species","volume":"10","author":"Bador","year":"2016","journal-title":"New Microbes New Infect"},{"key":"2021012006032234000_dkaa440-B6","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1128\/AAC.00341-11","article-title":"First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM","volume":"55","author":"Bador","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B7","doi-asserted-by":"crossref","first-page":"14.","DOI":"10.3390\/pathogens8010014","article-title":"Motility, biofilm formation and antimicrobial efflux of sessile and planktonic cells of Achromobacter xylosoxidans","volume":"8","author":"Nielsen","year":"2019","journal-title":"Pathogens"},{"key":"2021012006032234000_dkaa440-B8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijantimicag.2018.09.001","article-title":"Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients","volume":"53","author":"D\u00edez-Aguilar","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2021012006032234000_dkaa440-B9","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.20604","article-title":"Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003)","volume":"101","author":"Aisenberg","year":"2004","journal-title":"Cancer"},{"key":"2021012006032234000_dkaa440-B10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"2021012006032234000_dkaa440-B11","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/AAC.39.9.1970","article-title":"DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa","volume":"39","author":"Yonezawa","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","article-title":"Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously","volume":"48","author":"Llanes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B13","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1128\/AAC.00101-11","article-title":"Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin","volume":"55","author":"Llanes","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B14","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/AAC.01107-07","article-title":"Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump","volume":"52","author":"Jeannot","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B15","doi-asserted-by":"crossref","first-page":"e00301-18.","DOI":"10.1128\/AAC.00301-18","article-title":"Overexpression of the efflux pumps SmeVWX and SmeDEF is a major cause of resistance to co-trimoxazole in Stenotrophomonas maltophilia","volume":"62","author":"S\u00e1nchez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B16","doi-asserted-by":"crossref","first-page":"e00290-17.","DOI":"10.1128\/AAC.00290-17","article-title":"Role of AxyZ transcriptional regulator in overproduction of AxyXY-OprZ multidrug efflux system in Achromobacter Species Mutants selected by tobramycin","volume":"61","author":"Bador","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"D\u00f6ring","year":"2012","journal-title":"J Cyst Fibros"},{"key":"2021012006032234000_dkaa440-B18","year":"2018"},{"key":"2021012006032234000_dkaa440-B19","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1128\/AAC.45.8.2263-2268.2001","article-title":"Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance","volume":"45","author":"Akasaka","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00338386","article-title":"Quinolone-resistant mutations of the gyrA gene of Escherichia coli","volume":"211","author":"Yoshida","year":"1988","journal-title":"Mol Gen Genet"},{"key":"2021012006032234000_dkaa440-B21","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.35.8.1647","article-title":"Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli","volume":"35","author":"Yoshida","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B22","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2021012006032234000_dkaa440-B23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijantimicag.2005.02.006","article-title":"Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments","volume":"25","author":"Hopkins","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"2021012006032234000_dkaa440-B24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"F\u00e0brega","year":"2009","journal-title":"Microb Biotechnol"},{"key":"2021012006032234000_dkaa440-B25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/AAC.43.2.406","article-title":"Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones","volume":"43","author":"Takenouchi","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apm.12896","article-title":"Replicon typing of plasmids in environmental Achromobacter sp. producing quinolone-resistant determinants","volume":"126","author":"Furlan","year":"2018","journal-title":"APMIS"},{"key":"2021012006032234000_dkaa440-B27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetmic.2005.01.021","article-title":"Antimicrobial susceptibility and molecular characterization of avian pathogenic Escherichia coli isolates","volume":"107","author":"Zhao","year":"2005","journal-title":"Vet Microbiol"},{"key":"2021012006032234000_dkaa440-B28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijantimicag.2004.11.012","article-title":"Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa","volume":"25","author":"Lee","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"2021012006032234000_dkaa440-B29","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.40.10.2380","article-title":"Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals","volume":"40","author":"Everett","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.46.3.665-671.2002","article-title":"Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility","volume":"46","author":"Valdezate","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B31","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/AAC.45.6.1879-1881.2001","article-title":"Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia","volume":"45","author":"Alonso","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jac\/dkh094","article-title":"Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia","volume":"53","author":"Chang","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"2021012006032234000_dkaa440-B33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmi.2015.01.007","article-title":"High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates","volume":"21","author":"Garc\u00eda-Le\u00f3n","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2021012006032234000_dkaa440-B34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/AAC.41.5.1140","article-title":"Multiple antibiotic resistance in Stenotrophomonas maltophilia","volume":"41","author":"Alonso","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B35","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1128\/AAC.46.11.3386-3393.2002","article-title":"Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF","volume":"46","author":"S\u00e1nchez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2021012006032234000_dkaa440-B36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jac\/dky024","article-title":"Overexpression of Stenotrophomonas maltophilia major facilitator superfamily protein MfsA increases resistance to fluoroquinolone antibiotics","volume":"73","author":"Vattanaviboon","year":"2018","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/2\/297\/35925251\/dkaa440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/2\/297\/35925251\/dkaa440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:11:15Z","timestamp":1611151875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/2\/297\/5959825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,6]]},"published-print":{"date-parts":[[2021,1,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa440","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2]]},"published":{"date-parts":[[2020,11,6]]}}}